Universe Pharmaceuticals Inc Revenue per Employee (UPC), current and historic results, rankings and more, quarterly fundamentals - CSIMarket
CSIMarket Company Name, Ticker, Suppliers, else..
 


• Sales per Employee
• Income per Employee
• Inventory Turnover
• Asset Turnover
• Receivables Turnover
Universe Pharmaceuticals Inc  (NASDAQ: UPC)
 

Universe Pharmaceuticals Inc's Revenue per Employee

Quarterly Results, Trends, Rankings, Statistics, Cumulative Sales


With a revenue increase of 55175.24% in the fourth quarter 2025, year on year to cumulative value of $17,859 million, Universe Pharmaceuticals Inc's revenue per employee grew on a trailing twelve months basis to $ 82,679,315, this marks a new company high.
Within the Healthcare sector Universe Pharmaceuticals Inc achieved the highest revenue per employee. While Universe Pharmaceuticals Inc's total ranking has deteriorated compared to the previous quarter from to 7. Universe Pharmaceuticals Inc has 216 employees.


What is Sales per Employee Ratio?






Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

UPC Revenue per Employee (Sep 30 2025)
IV. Quarter		 0
III. Quarter		 0
II. Quarter		 0
I. Quarter		 (Sep 30 2023)
IV. Quarter
Y / Y Revenue Change 55175.24 % - - - -19.52 %
Sales per Employee (TTM) $ 82,679,315 149,577 149,577 149,577 149,577
UPC's Total Ranking # 7 # # # #
Seq. Revenue Change - - - - -

UPC Company Profile >> Back to UPC Efficiency Comparisons >> Compare UPC Sales per Employee to its Competitors

Revenue per Employee Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 1
Healthcare Sector # 1
Overall Market # 7

Revenue per Employee Statistics
High Average Low
$ 82,679,315 $ 20,809,220 $ 149,577
(Sep 30 2025)   (Sep 30 2023)



Financial Statements
Universe Pharmaceuticals Inc's Revenue MRQ $ 17,859 Millions Visit UPC's Income Statement
Universe Pharmaceuticals Inc's Revenues TTM $ 17,859 Millions Visit UPC's aggregate revenue growth
What are UPC's Sales? Visit UPC's Sales by Segment




Other Ratios
Universe Pharmaceuticals Inc's Income per Employee
Employees in Major Pharmaceutical Preparations
Major Pharmaceutical Preparations Industry Revenue per Employee Trends and Statistics
Healthcare Sector Revenue per Employee Statistics
Revenue per Employee Trends for overall market
UPC's Revenue per Employee versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Revenue per Employee
Lowest Ranking Revenue per Employee
Revenue per Employee for UPC's Competitors
Revenue per Employee for UPC's Suppliers
Revenue per Employee for UPC's Customers

You may also want to know
UPC's Sales Growth Rates UPC's Pe Price to earnings ratio UPC's Receivables Turnover Ratio UPC's Stock Quote
UPC's Net Income Growth Rates UPC's Ps Price to Sales ratio UPC's Sales per Employee UPC's Asset Turnover Ratio
UPC's Net Margin UPC's Pb Price to Book ratio UPC's Financial Strength Ratios UPC's Dividend Payout Ratio
Date modified: 2026-07-07T13:48:41+00:00




Companies with similar Revenue per Employee for 12 months ending Sep 30 2025, within Healthcare Sector Revenue per Employee Revenue 12 months ending Sep 30 2025Number of Employees Sep 30 2025




Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.